APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs Produced by Fermentation Engineering

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drugs Produced by Fermentation Engineering Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchDrugs Produced by Fermentation Engineering Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs Produced by Fermentation Engineering Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drugs Produced by Fermentation Engineering Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs Produced by Fermentation Engineering Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs Produced by Fermentation Engineering Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drugs Produced by Fermentation Engineering market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drugs Produced by Fermentation Engineering market include Changchun GeneScience Pharmaceutical, Tonghua Dongbao Pharmaceutical, Sichuan Kelun Pharmaceutical, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Shanghai Fosun Pharmaceutical, 3SBio Inc, United Laboratories International Holdings and Shandong Kexing Bioproducts, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drugs Produced by Fermentation Engineering market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs Produced by Fermentation Engineering and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs Produced by Fermentation Engineering revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drugs Produced by Fermentation Engineering market.

Drugs Produced by Fermentation Engineering Segment by Company

Changchun GeneScience Pharmaceutical

Tonghua Dongbao Pharmaceutical

Sichuan Kelun Pharmaceutical

CSPC Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Shanghai Fosun Pharmaceutical

3SBio Inc

United Laboratories International Holdings

Shandong Kexing Bioproducts

Joincare Pharmaceutical Group

North China Pharma

Harbin Pharmaceutical Group

Gan and Lee Pharmaceuticals

Anhui Anke Biotechnology

Drugs Produced by Fermentation Engineering Segment by Type

Monoclonal Antibodies

Antibiotic

Human Growth Hormone

Pharmaceutical Amino Acids

Insulin

Others

Drugs Produced by Fermentation Engineering Segment by Application

Hospital

Clinic

Other

Drugs Produced by Fermentation Engineering Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drugs Produced by Fermentation Engineering status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drugs Produced by Fermentation Engineering key companies, revenue, market share, and recent developments.

3. To split the Drugs Produced by Fermentation Engineering breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drugs Produced by Fermentation Engineering market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drugs Produced by Fermentation Engineering significant trends, drivers, influence factors in global and regions.

6. To analyze Drugs Produced by Fermentation Engineering competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Produced by Fermentation Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Produced by Fermentation Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Produced by Fermentation Engineering.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs Produced by Fermentation Engineering industry.

Chapter 3: Detailed analysis of Drugs Produced by Fermentation Engineering company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drugs Produced by Fermentation Engineering in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drugs Produced by Fermentation Engineering in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drugs Produced by Fermentation Engineering Industry Trends Table 2. Drugs Produced by Fermentation Engineering Industry Drivers Table 3. Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges Table 4. Drugs Produced by Fermentation Engineering Industry Restraints Table 5. Global Drugs Produced by Fermentation Engineering Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drugs Produced by Fermentation Engineering Revenue Share by Company (2021-2026) Table 7. Global Drugs Produced by Fermentation Engineering Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drugs Produced by Fermentation Engineering Key Company Manufacturing Base & Headquarters Table 9. Global Drugs Produced by Fermentation Engineering Company, Product Type & Application Table 10. Global Drugs Produced by Fermentation Engineering Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drugs Produced by Fermentation Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monoclonal Antibodies Table 15. Significant Companies of Antibiotic Table 16. Significant Companies of Human Growth Hormone Table 17. Significant Companies of Pharmaceutical Amino Acids Table 18. Significant Companies of Insulin Table 19. Significant Companies of Others Table 20. Global Drugs Produced by Fermentation Engineering Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Drugs Produced by Fermentation Engineering Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Drugs Produced by Fermentation Engineering Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Drugs Produced by Fermentation Engineering Sales Value Share by Type (2021-2026) Table 24. Global Drugs Produced by Fermentation Engineering Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Table 26. Significant Companies of Clinic Table 27. Significant Companies of Other Table 28. Global Drugs Produced by Fermentation Engineering Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Drugs Produced by Fermentation Engineering Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Drugs Produced by Fermentation Engineering Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Drugs Produced by Fermentation Engineering Sales Value Share by Application (2021-2026) Table 32. Global Drugs Produced by Fermentation Engineering Sales Value Share by Application (2027-2032) Table 33. Global Drugs Produced by Fermentation Engineering Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Drugs Produced by Fermentation Engineering Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Drugs Produced by Fermentation Engineering Sales Value Share by Region (2021-2026) Table 36. Global Drugs Produced by Fermentation Engineering Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Drugs Produced by Fermentation Engineering Sales Value Share by Region (2027-2032) Table 38. Global Drugs Produced by Fermentation Engineering Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Drugs Produced by Fermentation Engineering Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Drugs Produced by Fermentation Engineering Sales Value Market Share by Country (2021-2026) Table 41. Global Drugs Produced by Fermentation Engineering Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Drugs Produced by Fermentation Engineering Sales Value Market Share by Country (2027-2032) Table 43. Changchun GeneScience Pharmaceutical Company Information Table 44. Changchun GeneScience Pharmaceutical Business Overview Table 45. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 47. Changchun GeneScience Pharmaceutical Recent Development Table 48. Tonghua Dongbao Pharmaceutical Company Information Table 49. Tonghua Dongbao Pharmaceutical Business Overview Table 50. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 52. Tonghua Dongbao Pharmaceutical Recent Development Table 53. Sichuan Kelun Pharmaceutical Company Information Table 54. Sichuan Kelun Pharmaceutical Business Overview Table 55. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 57. Sichuan Kelun Pharmaceutical Recent Development Table 58. CSPC Pharmaceutical Group Company Information Table 59. CSPC Pharmaceutical Group Business Overview Table 60. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 62. CSPC Pharmaceutical Group Recent Development Table 63. Shanghai Shyndec Pharmaceutical Company Information Table 64. Shanghai Shyndec Pharmaceutical Business Overview Table 65. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 67. Shanghai Shyndec Pharmaceutical Recent Development Table 68. Shanghai Fosun Pharmaceutical Company Information Table 69. Shanghai Fosun Pharmaceutical Business Overview Table 70. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 72. Shanghai Fosun Pharmaceutical Recent Development Table 73. 3SBio Inc Company Information Table 74. 3SBio Inc Business Overview Table 75. 3SBio Inc Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio Table 77. 3SBio Inc Recent Development Table 78. United Laboratories International Holdings Company Information Table 79. United Laboratories International Holdings Business Overview Table 80. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio Table 82. United Laboratories International Holdings Recent Development Table 83. Shandong Kexing Bioproducts Company Information Table 84. Shandong Kexing Bioproducts Business Overview Table 85. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio Table 87. Shandong Kexing Bioproducts Recent Development Table 88. Joincare Pharmaceutical Group Company Information Table 89. Joincare Pharmaceutical Group Business Overview Table 90. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 92. Joincare Pharmaceutical Group Recent Development Table 93. North China Pharma Company Information Table 94. North China Pharma Business Overview Table 95. North China Pharma Drugs Produced by Fermentation Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio Table 97. North China Pharma Recent Development Table 98. Harbin Pharmaceutical Group Company Information Table 99. Harbin Pharmaceutical Group Business Overview Table 100. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 102. Harbin Pharmaceutical Group Recent Development Table 103. Gan and Lee Pharmaceuticals Company Information Table 104. Gan and Lee Pharmaceuticals Business Overview Table 105. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio Table 107. Gan and Lee Pharmaceuticals Recent Development Table 108. Anhui Anke Biotechnology Company Information Table 109. Anhui Anke Biotechnology Business Overview Table 110. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio Table 112. Anhui Anke Biotechnology Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Drugs Produced by Fermentation Engineering Product Image Figure 2. Global Drugs Produced by Fermentation Engineering Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs Produced by Fermentation Engineering Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs Produced by Fermentation Engineering Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monoclonal Antibodies Image Figure 8. Antibiotic Image Figure 9. Human Growth Hormone Image Figure 10. Pharmaceutical Amino Acids Image Figure 11. Insulin Image Figure 12. Others Image Figure 13. Global Drugs Produced by Fermentation Engineering Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Drugs Produced by Fermentation Engineering Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Drugs Produced by Fermentation Engineering Sales Value Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Drugs Produced by Fermentation Engineering Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drugs Produced by Fermentation Engineering Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Drugs Produced by Fermentation Engineering Sales Value Share by Application (2021-2032) Figure 22. Global Drugs Produced by Fermentation Engineering Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Drugs Produced by Fermentation Engineering Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Drugs Produced by Fermentation Engineering Sales Value (2021-2032) & (US$ Million) Figure 25. North America Drugs Produced by Fermentation Engineering Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Drugs Produced by Fermentation Engineering Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Drugs Produced by Fermentation Engineering Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Drugs Produced by Fermentation Engineering Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Drugs Produced by Fermentation Engineering Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Drugs Produced by Fermentation Engineering Sales Value (2021-2032) & (US$ Million) Figure 31. South America Drugs Produced by Fermentation Engineering Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Drugs Produced by Fermentation Engineering Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Drugs Produced by Fermentation Engineering Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Antibiotic
  • Human Growth Hormone
  • Pharmaceutical Amino Acids
  • Insulin
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changchun GeneScience Pharmaceutical
  • Tonghua Dongbao Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • CSPC Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Shanghai Fosun Pharmaceutical
  • 3SBio Inc
  • United Laboratories International Holdings
  • Shandong Kexing Bioproducts
  • Joincare Pharmaceutical Group
  • North China Pharma
  • Harbin Pharmaceutical Group
  • Gan and Lee Pharmaceuticals
  • Anhui Anke Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drugs Produced by Fermentation Engineering Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drugs Produced by Fermentation Engineering Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drugs Produced by Fermentation Engineering Market Dynamics
  1. 2.1 Drugs Produced by Fermentation Engineering Industry Trends
  2. 2.2 Drugs Produced by Fermentation Engineering Industry Drivers
  3. 2.3 Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges
  4. 2.4 Drugs Produced by Fermentation Engineering Industry Restraints
3 Drugs Produced by Fermentation Engineering Market by Company
  1. 3.1 Global Drugs Produced by Fermentation Engineering Company Revenue Ranking in 2025
  2. 3.2 Global Drugs Produced by Fermentation Engineering Revenue by Company (2021-2026)
  3. 3.3 Global Drugs Produced by Fermentation Engineering Company Ranking (2024-2026)
  4. 3.4 Global Drugs Produced by Fermentation Engineering Company Manufacturing Base and Headquarters
  5. 3.5 Global Drugs Produced by Fermentation Engineering Company Product Type and Application
  6. 3.6 Global Drugs Produced by Fermentation Engineering Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drugs Produced by Fermentation Engineering Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drugs Produced by Fermentation Engineering Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drugs Produced by Fermentation Engineering Market by Type
  1. 4.1 Drugs Produced by Fermentation Engineering Type Introduction
  2. 4.1.1 Monoclonal Antibodies
  3. 4.1.2 Antibiotic
  4. 4.1.3 Human Growth Hormone
  5. 4.1.4 Pharmaceutical Amino Acids
  6. 4.1.5 Insulin
  7. 4.1.6 Others
  8. 4.2 Global Drugs Produced by Fermentation Engineering Sales Value by Type
  9. 4.2.1 Global Drugs Produced by Fermentation Engineering Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Drugs Produced by Fermentation Engineering Sales Value by Type (2021-2032)
  11. 4.2.3 Global Drugs Produced by Fermentation Engineering Sales Value Share by Type (2021-2032)
5 Drugs Produced by Fermentation Engineering Market by Application
  1. 5.1 Drugs Produced by Fermentation Engineering Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Drugs Produced by Fermentation Engineering Sales Value by Application
  6. 5.2.1 Global Drugs Produced by Fermentation Engineering Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs Produced by Fermentation Engineering Sales Value by Application (2021-2032)
  8. 5.2.3 Global Drugs Produced by Fermentation Engineering Sales Value Share by Application (2021-2032)
6 Drugs Produced by Fermentation Engineering Regional Value Analysis
  1. 6.1 Global Drugs Produced by Fermentation Engineering Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs Produced by Fermentation Engineering Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drugs Produced by Fermentation Engineering Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drugs Produced by Fermentation Engineering Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drugs Produced by Fermentation Engineering Sales Value (2021-2032)
  7. 6.3.2 North America Drugs Produced by Fermentation Engineering Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drugs Produced by Fermentation Engineering Sales Value (2021-2032)
  10. 6.4.2 Europe Drugs Produced by Fermentation Engineering Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drugs Produced by Fermentation Engineering Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drugs Produced by Fermentation Engineering Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drugs Produced by Fermentation Engineering Sales Value (2021-2032)
  16. 6.6.2 South America Drugs Produced by Fermentation Engineering Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drugs Produced by Fermentation Engineering Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drugs Produced by Fermentation Engineering Sales Value Share by Country, 2025 VS 2032
7 Drugs Produced by Fermentation Engineering Country-level Value Analysis
  1. 7.1 Global Drugs Produced by Fermentation Engineering Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drugs Produced by Fermentation Engineering Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drugs Produced by Fermentation Engineering Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drugs Produced by Fermentation Engineering Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drugs Produced by Fermentation Engineering Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drugs Produced by Fermentation Engineering Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drugs Produced by Fermentation Engineering Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changchun GeneScience Pharmaceutical
  2. 8.1.1 Changchun GeneScience Pharmaceutical Company Information
  3. 8.1.2 Changchun GeneScience Pharmaceutical Business Overview
  4. 8.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  6. 8.1.5 Changchun GeneScience Pharmaceutical Recent Developments
  7. 8.2 Tonghua Dongbao Pharmaceutical
  8. 8.2.1 Tonghua Dongbao Pharmaceutical Company Information
  9. 8.2.2 Tonghua Dongbao Pharmaceutical Business Overview
  10. 8.2.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  12. 8.2.5 Tonghua Dongbao Pharmaceutical Recent Developments
  13. 8.3 Sichuan Kelun Pharmaceutical
  14. 8.3.1 Sichuan Kelun Pharmaceutical Company Information
  15. 8.3.2 Sichuan Kelun Pharmaceutical Business Overview
  16. 8.3.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  18. 8.3.5 Sichuan Kelun Pharmaceutical Recent Developments
  19. 8.4 CSPC Pharmaceutical Group
  20. 8.4.1 CSPC Pharmaceutical Group Company Information
  21. 8.4.2 CSPC Pharmaceutical Group Business Overview
  22. 8.4.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  24. 8.4.5 CSPC Pharmaceutical Group Recent Developments
  25. 8.5 Shanghai Shyndec Pharmaceutical
  26. 8.5.1 Shanghai Shyndec Pharmaceutical Company Information
  27. 8.5.2 Shanghai Shyndec Pharmaceutical Business Overview
  28. 8.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  30. 8.5.5 Shanghai Shyndec Pharmaceutical Recent Developments
  31. 8.6 Shanghai Fosun Pharmaceutical
  32. 8.6.1 Shanghai Fosun Pharmaceutical Company Information
  33. 8.6.2 Shanghai Fosun Pharmaceutical Business Overview
  34. 8.6.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  36. 8.6.5 Shanghai Fosun Pharmaceutical Recent Developments
  37. 8.7 3SBio Inc
  38. 8.7.1 3SBio Inc Company Information
  39. 8.7.2 3SBio Inc Business Overview
  40. 8.7.3 3SBio Inc Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  41. 8.7.4 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio
  42. 8.7.5 3SBio Inc Recent Developments
  43. 8.8 United Laboratories International Holdings
  44. 8.8.1 United Laboratories International Holdings Company Information
  45. 8.8.2 United Laboratories International Holdings Business Overview
  46. 8.8.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  47. 8.8.4 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio
  48. 8.8.5 United Laboratories International Holdings Recent Developments
  49. 8.9 Shandong Kexing Bioproducts
  50. 8.9.1 Shandong Kexing Bioproducts Company Information
  51. 8.9.2 Shandong Kexing Bioproducts Business Overview
  52. 8.9.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio
  54. 8.9.5 Shandong Kexing Bioproducts Recent Developments
  55. 8.10 Joincare Pharmaceutical Group
  56. 8.10.1 Joincare Pharmaceutical Group Company Information
  57. 8.10.2 Joincare Pharmaceutical Group Business Overview
  58. 8.10.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  60. 8.10.5 Joincare Pharmaceutical Group Recent Developments
  61. 8.11 North China Pharma
  62. 8.11.1 North China Pharma Company Information
  63. 8.11.2 North China Pharma Business Overview
  64. 8.11.3 North China Pharma Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  65. 8.11.4 North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio
  66. 8.11.5 North China Pharma Recent Developments
  67. 8.12 Harbin Pharmaceutical Group
  68. 8.12.1 Harbin Pharmaceutical Group Company Information
  69. 8.12.2 Harbin Pharmaceutical Group Business Overview
  70. 8.12.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  72. 8.12.5 Harbin Pharmaceutical Group Recent Developments
  73. 8.13 Gan and Lee Pharmaceuticals
  74. 8.13.1 Gan and Lee Pharmaceuticals Company Information
  75. 8.13.2 Gan and Lee Pharmaceuticals Business Overview
  76. 8.13.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio
  78. 8.13.5 Gan and Lee Pharmaceuticals Recent Developments
  79. 8.14 Anhui Anke Biotechnology
  80. 8.14.1 Anhui Anke Biotechnology Company Information
  81. 8.14.2 Anhui Anke Biotechnology Business Overview
  82. 8.14.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio
  84. 8.14.5 Anhui Anke Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst